Artelo Biosciences Inc (ARTL)
1.42
+0.06
(+4.41%)
USD |
NASDAQ |
May 17, 16:00
1.42
0.00 (0.00%)
After-Hours: 20:00
Artelo Biosciences Net Income (Quarterly): -2.483M for March 31, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -2.483M |
| December 31, 2023 | -3.073M |
| September 30, 2023 | -2.449M |
| June 30, 2023 | -1.599M |
| March 31, 2023 | -2.168M |
| December 31, 2022 | -3.339M |
| September 30, 2022 | -2.33M |
| June 30, 2022 | -2.449M |
| March 31, 2022 | -1.965M |
| November 30, 2021 | -2.548M |
| August 31, 2021 | -1.887M |
| May 31, 2021 | -2.250M |
| February 28, 2021 | -1.866M |
| November 30, 2020 | -1.435M |
| August 31, 2020 | -1.027M |
| May 31, 2020 | -0.9512M |
| February 29, 2020 | -1.370M |
| November 30, 2019 | -1.306M |
| August 31, 2019 | -0.8456M |
| May 31, 2019 | -0.3449M |
| February 28, 2019 | -0.4248M |
| Date | Value |
|---|---|
| November 30, 2018 | -0.5569M |
| August 31, 2018 | -0.6901M |
| May 31, 2018 | -0.5779M |
| February 28, 2018 | -0.7985M |
| November 30, 2017 | -0.2771M |
| August 31, 2017 | -0.1157M |
| May 31, 2017 | -0.0966M |
| February 28, 2017 | -0.013M |
| November 30, 2016 | -0.0095M |
| August 31, 2016 | -0.0043M |
| May 31, 2016 | -0.005M |
| February 29, 2016 | -0.0051M |
| November 30, 2015 | -0.0152M |
| August 31, 2015 | -0.0046M |
| May 31, 2015 | -0.0025M |
| February 28, 2015 | -0.0062M |
| November 30, 2014 | -0.002M |
| August 31, 2014 | -0.0005M |
| May 31, 2014 | -0.0081M |
| February 28, 2014 | -0.0066M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-3.339M
Minimum
Dec 2022
-0.3449M
Maximum
May 2019
-1.884M
Average
-1.926M
Median
Net Income (Quarterly) Benchmarks
| Johnson & Johnson | 3.255B |
| NovaBay Pharmaceuticals Inc | -3.214M |
| Palatin Technologies Inc | -8.436M |
| iBio Inc | -8.211M |
| Theriva Biologics Inc | -5.165M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 2.589M |
| EPS Diluted (Quarterly) | -0.78 |
| Enterprise Value | -3.026M |
| Earnings Yield | -222.5% |